The Pulse of Asia
The Pulse of Asia is a series of innovative international symposia taking place annually. The Pulse implies inside knowledge, drawing on the fact that the pulse provides important information once its full potential has been realized. As Asia has contributed so much in the past to the inter pretation of the pulse, we felt the need to set our own standards for both Asia and the rest of the world, and to actively further research in the field. The symposia are thus designed as a forum for the most recent and noteworthy advances in epidemiology, pathophysiology, diagnostics, therapeutics and prevention related to vascular disease.
Aims
• Exchange of cutting edge knowledge on vascular research • Achieve and further fruitful collaboration on vascular research • Understand pulsatile phenomena with an interdisciplinary approach across various specialties including cardiology, nephrology, neurology, endocrinology and diabetology, gerontology and general medicine 
Conditions
All manuscripts are subject to editorial review. Manuscripts are received with the explicit understanding that they are not under simultaneous consideration by any other publication. Submission of an article for publication implies transfer of the copyright from the author to the publisher upon acceptance. Accepted papers become the permanent property of Pulse and may not be reproduced by any means, in whole or in part, without the written consent of the publisher. It is the author's responsibility to obtain permission to reproduce illustrations, tables, etc. from other publications.
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The certainty and uncertainty of one's fate are discussed from both methodological and epidemiological perspectives, using examples of diseases for which treatment and prognosis have dramatically changed. Despite profound insights into the human genome, personalized genetically tailored medicine still lies in the future. Religious, spiritual and philoso phical dimensions are discussed, as are the ways in which they may help people cope with these new insights into their future, e.g. the promise of an afterlife. This publication aims to bridge the different fields dealing with this area by addressing the challenges faced and encouraging dialogue. It will be of interest to all readers who deal with ethical problems of prognosis, particularly in medicine, as well as to theologians and sociologists.
Based on the symposium 'GenEthics and Religion ' (Basel, Switzerland, May 2008) , this volume examines the role religion can play in establishing ethical guidelines to protect human life in the face of rapid advances in biology and gene technology. It does so with contributions by philosophers, theologians, human geneticists, and several bioethicists representing the Christian, Jewish, Islamic and Buddhist perspectives. The essays illustrating a diversity of views and expressing the problems and self-critical reflectiveness of religious ethicists are brought up to date and discuss the importance of religious ethics in society's discourse on gene technology.
